Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for January 2008.

Pharmaceutical Technology
Volume 32, Issue 1

Meissner Debuts Green Website

Meissner (Camarillo, CA) launched a new website called Green Docs at http://www.meissner.com/greendocs. Green Docs makes product inserts, which were previously printed, available on the Internet 24 hours a day. The implementation of Green Docs is part of Meissner's overall plan to become an environmentally friendly manufacturer. Meissner says that customers can help save more than one acre of forested land annually by accessing and downloading these e-documents. Green Docs provides information and guidance on such topics as product specifications, filter integrity testing, and proper product installation.

Acquisitions
Cambridge Major Labs Acquires ChemShop

Cambridge Major Laboratories (CML, Germantown, WI) acquired ChemShop (Weert the Netherlands), a European supplier of active pharmaceutical ingredient (API) development services. The newly combined company is one of the largest pharmaceutical-chemistry development organizations in the Western hemisphere, according to CML. The merged companies have 140 employees at three sites in the US and Europe. ChemShop was renamed Cambridge Major Laboratories Europe.

ChemShop has provided process development and manufacturing services to the pharmaceutical industry for nine years. All of ChemShop's management and personnel will continue to operate the business at the Weert facility, which includes research and development laboratories, kilo-laboratory suites, and a pilot plant. The ChemShop facility provides intermediates and APIs on scales from grams to hundreds of kilograms.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here